APA (7th ed.) Citation

T, P., AM, P., P, W., P, T., Q, W., Y, H., . . . S, T. (2026). Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial. NPJ precision oncology, 10(1), 50. https://doi.org/10.1038/s41698-025-01253-5

Chicago Style (17th ed.) Citation

T, Pu, et al. "Exploratory Biomarker Analysis of RAS/BRAF Somatic Mutations and Gene Expression Signatures for Predicting Treatment Effects of Aflibercept in the Velour Trial." NPJ Precision Oncology 10, no. 1 (2026): 50. https://doi.org/10.1038/s41698-025-01253-5.

MLA (9th ed.) Citation

T, Pu, et al. "Exploratory Biomarker Analysis of RAS/BRAF Somatic Mutations and Gene Expression Signatures for Predicting Treatment Effects of Aflibercept in the Velour Trial." NPJ Precision Oncology, vol. 10, no. 1, 2026, p. 50, https://doi.org/10.1038/s41698-025-01253-5.